Condition: Estrogen Receptor Negative · HER2 Positive Breast Carcinoma · HER2/Neu Negative · Sponsor: M.D. Anderson Cancer Center
This clinical trial studies eliminating surgery and/or radiation therapy in treating breast cancer patients. In HER2 positive and triple negative breast cancers, after systemic therapy, when image-guided biopsy shows no residual cancer, patients then receive standard breast radiotherapy with no surgery. In ER positive/HER2 negative breast cancers, after endocrine therapy and ablative radiotherapy, when image-guided biopsy shows no residual cancer, patients then receive standard endocrine therapy with no surgery. For patients who have HER2 positive and triple negative breast cancers and standard surgery, after systemic therapy, breast radiotherapy is being eliminated when the pathology from surgery shows no residual cancer.
This description comes directly from the study's public registry record.
Henry Kuerer · 713-745-5043 · hkuerer@mdanderson.org
Always discuss trial participation with your own doctor first.
| MD Anderson Cancer Center - Banner | Gilbert, Arizona, United States | Completed |
| Baptist MD Anderson Cancer Center | Jacksonville, Florida, United States | Recruiting |
| Queen's Medical Center | Honolulu, Hawaii, United States | Completed |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees | Voorhees Township, New Jersey, United States | Recruiting |
| Carolinas Medical Center/Levine Cancer Institute | Charlotte, North Carolina, United States | Recruiting |
| University of Pittsburgh Cancer Institute (UPCI) | Pittsburgh, Pennsylvania, United States | Recruiting |
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02945579